Register information Patent

DE file number : 60 2008 063 441.8 (Status: pending/in force, Query started: April 28, 2025)

Please note: This English version is a non-binding translation of the German register excerpt. Only the German version of the register excerpt is legally binding.

Master data
INIDCriterionFieldContent
Type of IP rightSARTPatent
StatusSTPending/in force
21DE file number DAKZ60 2008 063 441.8
96EP file numberEAKZ14 19 7779.3
97EP publication numberEPN2915564
54Designation/titleTIGegenmittel für Faktor-XA-Hemmer und Verfahren zur Verwendung davon
51IPC main classICM
(ICMV)		 A61P 7/04 (2006.01)
51IPC secondary class(es)ICS
(ICSV)		 A61K 38/48 (2006.01)
22DE application dateDATSep 26, 2008
96EP application dateEATSep 26, 2008
43Date of first publicationOTSep 9, 2015
Date of publication of grantPETNov 4, 2020
71/73Applicant/ownerINHAlexion Pharmaceuticals, Inc., Boston, MA, US
72InventorINLU, Genmin, Burlingame, CA California 94010, US; PHILLIPS, David R., Hillsborough, CA 94010, US; ANDRE, Patrick, San Francisco, CA California 94401, US; SINHA, Uma, San Francisco, CA California 94127, US
Address for service RWS Group, Translation Division, CHALFONT ST PETER, Bucks SL9 9FG, GB
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
976343 P
Sep 28, 2007
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
90574 P
Aug 20, 2008
Due dateFT
FG		Sep 30, 2025
Annual fee for the 18th year Patent fees
Patent division in charge 44
97EP language of publicationELANGEN - Englisch
84Designated EP contracting statesEDSAT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR
Published EP/WO documentsEPWOPNOriginal document: EP000002915564
Searchable text: EP000002915564
Original document: EP000002915564B1
Searchable text: EP000002915564B1
43Date of first publicationEVTSep 9, 2015
Date of the first transfer into DPMAregisterEREGTSep 10, 2015
Date of the (most recent) update in DPMAregisterREGTOct 2, 2024
(Show all update days)(Hide all update days)
  • Oct 2, 2024
    • Due date: changed
  • Sep 19, 2024
    • St.36: changed (technical change)
  • Oct 3, 2023; Oct 5, 2022; Oct 6, 2021; Sep 23, 2021; Apr 16, 2021; Feb 11, 2021; Jan 19, 2021; Nov 26, 2020; Oct 19, 2020; Oct 15, 2020; Aug 13, 2019; May 2, 2019; Jul 13, 2017; Mar 9, 2017
    • Historical data not available for this/these date(s)
  • Sep 10, 2015
    • Date of the first transfer into DPMAregister
Procedural data
No.Kind of procedureLegal statusDate of legal/procedural statusPublication dateAlle Details anzeigen
1 Procedure relating to EP application EPO 1st publication Sep 9, 2015  Details anzeigen
2 Publications Publication of a mention regarding EP 1st publication by DPMA Oct 22, 2015 Oct 22, 2015 Details anzeigen
3 Procedure relating to EP application EPO publication of mention regarding patent grant (beginning of opposition period) Nov 4, 2020  Details anzeigen
4 Publications Publication by DPMA of mention regarding EP patent grant Nov 26, 2020 Nov 26, 2020 Details anzeigen
5 New applicant/owner details New applicant/owner details Jan 18, 2021 Feb 25, 2021 Details anzeigen
6 Procedure relating to EP application No opposition to patent grant filed, or opposition proceedings at EPO completed without decision Aug 5, 2021 Oct 28, 2021 Details anzeigen
View procedures Procedure relating to EP application (No.: 1)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO 1st publication
Date of legal/procedural statusVSTTSep 9, 2015
View procedures Publications (No.: 2)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication of a mention regarding EP 1st publication by DPMA
Date of legal/procedural statusVSTTOct 22, 2015
Issue numberHN43
YearPJ2015
Publication dateVTOct 22, 2015
Type of publicationPARTBibliographic data
View procedures Procedure relating to EP application (No.: 3)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO publication of mention regarding patent grant (beginning of opposition period)
Date of legal/procedural statusVSTTNov 4, 2020
Date of update of the procedureREGTOct 15, 2020
View procedures Publications (No.: 4)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication by DPMA of mention regarding EP patent grant
Date of legal/procedural statusVSTTNov 26, 2020
Issue numberHN48
YearPJ2020
Publication dateVTNov 26, 2020
Type of publicationPARTBibliographic data
PartHTPart 5
Date of update of the procedureREGTNov 26, 2020
View procedures New applicant/owner details (No.: 5)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTJan 18, 2021
Issue numberHN8
YearPJ2021
Publication dateVTFeb 25, 2021
Type of publicationPARTBibliographic data
PartHTPart 3
71/73Applicant/ownerINHAlexion Pharmaceuticals, Inc., Boston, MA, US
71/73Previous applicant/ownerINHFPortola Pharmaceuticals, Inc., South San Francisco, Calif., US
Date of update of the procedureREGTApr 16, 2021
View procedures Procedure relating to EP application (No.: 6)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTNo opposition to patent grant filed, or opposition proceedings at EPO completed without decision
Date of legal/procedural statusVSTTAug 5, 2021
Issue numberHN43
YearPJ2021
Publication dateVTOct 28, 2021
Type of publicationPARTBibliographic data
PartHTPart 3
Date of update of the procedureREGTOct 6, 2021